Hepatocellular carcinoma with intra-atrial tumor thrombi: A report of three cases responsive to thalidomide treatment and literature review

Oncology

Volumn 67, Issue 3-4, 2004, Pages 320-326

  Chang, Jang Yang ^a   Ka, Wann Shen ^b   Chao, Tsu Yi ^c   Liu, Tsang Wu ^a   Chuang, Tsai Rong ^a   Chen, Li Tzong ^a,d,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Review; Right atrium; Thalidomide; Tumor thrombi

Indexed keywords

ALPHA FETOPROTEIN; THALIDOMIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; FEMALE; HEART RIGHT ATRIUM; HUMAN; INFERIOR CAVA VEIN; LIVER CELL CARCINOMA; LOW DRUG DOSE; MALE; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; SERUM; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR THROMBUS;

EID: 9244226015     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081333     Document Type: Article

References (44)

1. Edmonson H, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
2. Kew MC, Paterson AC: Unusual clinical presentations of HCC. Trop Gastroenterol 1985;6:10-22.
3. Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H: Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med 1984;108:989-992.
4. Chua SO, Chiang CW, Lee YS, Liaw YF, Chang CH, Hung JS: Echocardiographic findings of mobile atrial hepatocellular carcinoma: Report of five cases. J Ultrasound Med 1989;8:347-352.
5. Lei MH, Ko YL, Kuan P, Lien WP, Chen DS: Metastasis of hepatocellular carcinoma to the heart: Unusual patterns in three cases with antemortem diagnosis. J Formos Med Assoc 1992;91:457-461.
6. Ayoola EA, Olubuyide IO, Thomas J: Cardiovascular systemic invasion by hepatocellular carcinoma: Incidence and pattern in a West African population. Afr J Med Med Sci 1994;23:61-66
7. Tse HF, Lau CP, Lau YK, Lai CL: Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma. Clin Cardiol 1996;19:211-213.
8. Cheng CY, Chien ST, Chen TY, Chen KS, Wong FN, Lin CK, Lin CS: Hepatocellular carcinoma with metastasis to right atrium - A report of three cases. Kaohsiung J Med Sci 1995;11:528-536.
9. Ehrich DA, Wideman JJ, Berger RL, Abelmann WH: Intracavitary cardiac extension of hepatoma. Ann Thorac Surg 1975;19:206-211.
10. Goto H, Kaneko Y, Utoh J, Nishimura K, Miyauchi Y, Iwanaga K: Surgery of hepatoma with intracavitary cardiac extension. Heart Vessels 1986;2:60-62.
11. Miller DL, Katz NM, Pallas RS: Hepatoma presenting as a right atrial mass. Am Heart J 1987;114:906-908.
12. Fujisaki M, Kurihara E, Kikuchi K, Nishikawa K, Uematsu Y: Hepatocellular carcinoma with tumor thrombus extending into right atrium: Report of a successful resection with the use of cardiopulmonary bypass. Surgery 1991;109:214-219.
13. Lamberts R, Nitsche R, de Vivie RE, Peitsch W, Schauer A, Schuster R, Tebbe U, Kreuzer H, Creutzfeldt W: Budd-Chiari syndrome as the primary manifestation of a fibrolamellar hepatocellular carcinoma. Digestion 1992;53:200-209.
14. Masaki N, Hayashi S, Maruyama T, Okabe H, Matsukawa M, Unno J, Maekawa S, Oka T, Tani M, Matsueda K, et al: Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries. Cancer Chemother Pharmacol 1994;33:S7-S11.
15. Iemura J, Aoshima M, Ishigami N, Kaneda T, Oba N: Surgery for hepatocellular carcinoma with tumor thrombus in the right atrium. Hepatogastroenterology 1997;44:824-825.
16. Wu CC, Hseih S, Ho WM, Tang JS, Liu TJ, P'eng FK: Surgical treatment for recurrent hepatocellular carcinoma with tumor thrombi in right atrium: Using cardiopulmonary bypass and deep hypothermic circulatory arrest. J Surg Oncol 2000;74:227-231.
17. Saisse J, Hardwigsen J, Castellani P, Caus T, Le Treut YP: Budd-Chiari syndrome secondary to intracardiac extension of hepatocellular carcinoma. Two cases treated by radical resection. Hepatogastroenterology 2001;48:836-839.
18. Georgen M, Regimbeau JM, Kianmanesh R, Marty J, Farges O, Belghiti J: Removal of hepatocellular carcinoma extending in the right atrium without extracorporeal bypass. J Am Coll Surg 2002;195:892-894.
19. Kubota H, Takamoto S, Kotsuka Y, Miyairi T, Murakawa T, Makuuchi H, Kawauchi M, Furuse A, Sudo K: Surgical treatment of malignant tumors of the right heart. Jpn Heart J 2002;43:263-271.
20. Tsai TP, Yu JM: Minimally invasive cardiac surgery for resection of right atrial hepatic tumor in an octogenarian. Chinese Med J 2002;65:345-347.
21. Kashima Y, Miyazaki M, Ito H, Kaiho T, Nakagawa K, Ambiru S, Shimizu H, Furuya S, Nakajima N: Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol 1999;14:922-927.
22. Dazai Y, Katoh T, Katoh I, Sueda S, Yoshida R: Effectiveness of chemoembolization therapy for right atrial tumor thrombus associated with hepatocellular carcinoma. Chest 1989;96:434-436.
23. Chen CP, Chao Y, Li CP, Lai MY, Chi KH, Yen SH, Chang FY, Lee SD: Radiotherapy is effective in the treatment of hepatocellular carcinoma with right atrium invasion - Report of a case. Therapeut Radiol Oncol 2000;7:215-220.
24. Ng SSW, Brown M, Figg WD: Thalidomide, an antiangiogenic agent with clinical activity in cancer. Biomed Pharmacother 2002;56:194-199.
25. Chen LT, Liu TW, Hsu C, et al: Thalidomide in human hepatocellular carcinoma. In Joint Conference of the NHRI and AACR: 'Hepatitis and Hepatocellular Carcinoma: Novel Approaches', Taipei, December 8th-10th, 2000.
26. Patt YZ, Hassan MM, Zeldis JB, Schnier J, Frome A, Abbruzzese JL, Woff RA, Brown TD, Ellis M, Chansangavej C: Phase II trial of thalomid (thalidomide) for treatment of nonresectable hepatocellular carcinoma (HCC). Proc Am Soc Clin Oncol 2000;19:266a.
27. Hsu C, Chen CN, Chen LT, Wu CY, Yang PM, Lai MY, Lee PH, Cheng AL: Low-dose thalidomide treatment of advanced hepatocellular carcinoma. Oncology 2003;65:242-249.
28. Hill JD, Hetzer R: Surgery of tumors of the subdiaphragmatic inferior vena cava: Report of two cases and review of literature. J Thorac Cardiovasc Surg 1978;76:38-42.
29. Ohwada S, Tanahashi Y, Kawashima Y, Satoh Y, Nakamura S, Kobayashi I, Ohya T, Ishikawa S, Ohtaki A, Iino Y, et al: Surgery for tumor thrombi in the right atrium and inferior vena cava of patients with recurrent hepatocellular carcinoma. Hepatogastroenterology 1994;41:154-157.
30. Baba HA, Engers R, Heintzen MP: Right atrial metastasis as primary clinical manifestation of hepatocellular carcinoma. Int J Cardiol 1995;47:281-284.
31. Chu MW, Aboguddah A, Kraus PA, Dewer LR: Urgent heart surgery for an atrial mass: Metastatic hepatocellular carcinoma. Ann Thorac Surg 2001;72:931-933.
32. Wilson K, Guardino J, Shapira OM: Pulmonary tumor embolism as a presenting feature of cavoatrial hepatocellular carcinoma. Chest 2001;119:657-658.
33. Peng SY, Wu CC, Chang CP, Peng SK, Ho WM: Metastatic hepatocellular carcinoma of the right atrium causing ventricular outflow tract obstruction during induction of anesthesia - A case report. Acta Anaesthesiol Sin 2002;40:205-208.
34. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J; EASL Panel of Experts on HCC: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
35. Tanaka A, Morimoto T, Ozaki N, Ikai I, Yamamoto Y, Tsunekawa S, Kitai T, Yamaoka Y: Extension of surgical indication for advanced hepatocellular carcinoma: Is it possible to prolong life span or improve quality of life? Hepatogastroenterology 1996;43:1172-1181.
36. McBride WG: Thalidomide and congenital abnormalities. Lancet 1968;2:1358.
37. D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994;91:4082-4085.
38. Kruse FE, Joussen AM, Rohrschneider K, Becker MD, Volcker HE: Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Klin Exp Ophthalmol 1998;236:461-466.
39. Kong HL, Boyer MJ, Lim R, Clarke S, Millward MJ, Wong JE: Phase II trial of thalidomide in unresectable hepatocellular carcinoma (HCC) - A Cancer Therapeutics Research Group (CTRG) study. Proc Am Soc Clin Oncol 2001;20:133b.
40. Schwartz JD, Sung MW, Lehrer D, Goldenberg A, Muggia F, Volm M: Thalidomide for unresectable hepatocellular cancer (HCC) with optional interferon-α upon disease progression. Proc Am Soc Clin Oncol 2002;21:10b.
41. Lin AY, Brophy N, Fisher GA, So S, Biggs C, Yock T, Levitt L: Phase II study of thalidomide in patients (pts) with unresectable hepatocellular carcinoma (HCC). Proc Am Soc Clin Oncol 2002;21:97b.
42. Takeda Y, Togashi H, Shinzawa H, Miyano S, Ishii R, Karasawa T, Takeda Y, Saito T, Saito K, Haga H, Matsuo T, Aoki M, Mitsuhashi H, Watanabe H, Takahashi T: Spontaneous regression of hepatocellular carcinoma and review of literature. J Gastroenterol Hepatol 2000;15:1079-1086.
43. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, Chuang CN, Yang PC, Wang TH, Lin JT, Lee CZ: Growth rate of asymptomatic hepatocellular carcinoma and its clinical applications. Gastroenterology 1985;89:259-266.
44. Patt YZ, Hassan MM, Lozano RD, Ellis M, Peterson JA, Waugh KA: Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide. Am J Clin Oncol 2000;23:319-322.